| Description |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Pharmasol |
|
| Product Type |
Product Size |
| Injection
|
1'S |
| Product Company |
| Helix pharma
|
Doxorubicin 50mg/25ml
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Roche Pharma |
Pertuzumab 420mg/14ml |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Martin Dow |
Ondansetron 8mg/4ml |
| Product Type |
Product Size |
| Tablets |
28'S |
| Product Company |
| Himmel Pharma |
Bicalutamide 50mg |
| Product Type |
Product Size |
| Tablet |
10'S |
| Product Company |
| Martin Dow |
Ondansetron 8mg |
| Content | Vincristine is a chemotherapy drug that belongs to a group of drugs called vinca alkaloids. Vincristine works by stopping the cancer cells from separating into 2 new cells. So, it stops the growth of the cancer. | Doxorubicin is a type of chemotherapy drug called an anthracycline. It slows or stops the growth of cancer cells by blocking an enzyme called topo isomerase 2. Cancer cells need this enzyme to divide and grow.
| "
Pertuzumab is a monoclonal antibody. . Monoclonal antibodies work by attaching to proteins on or in cancer cells. Human epidermal growth factor 2 (HER2) is a protein that makes cells grow and divide. | Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. | Bicalutamide belongs to the group of medicines called antiandrogens. It works by blocking the effects of testosterone (a male hormone), which helps stop the growth and spread of cancer cells.
| Ondansetron is one of the medications most commonly used for the empiric treatment of nausea and vomiting. Ondansetron has excellent utility as an antiemetic drug, and it is effective against nausea and vomiting of various etiologies. |
Reviews
There are no reviews yet.